Cooley, Davis Polk Assist Chinese Biopharma’s Private Placement
Yiming Liu, partner in charge of Cooley’s Shanghai office, was quoted in Asia Business Law Journal on the outlook of Asia’s pharmaceutical and life sciences industry and key legal areas of focus for cross-border transactions. Partners Will Cai, Jie Zhang and Francis Wheeler also were mentioned for leading the Cooley team in advising Gracell Biotechnologies on its private placement financing of up to $150 million.
Read about Gracell Biotechnologies’ private placement financing
Related contacts
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.